November 27, 2017 09:32 AM ESTUpdated 09:58 AM
News Briefing

In­trex­on taps new COO, CBO in ex­ec­u­tive reshuf­fle; De­nali tar­gets up to $182M in IPO

Amber Tong

→ An­oth­er round of lead­er­ship changes is tak­ing place at In­trex­on $XON: re­tired lieu­tenant gen­er­al Thomas Bo­stick is slat­ed to re­place COO An­drew Last; …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

Bris­tol My­ers re­veals more job cuts in New Jer­sey

Mer­ck halts Phase 3 tri­al with PAH drug Win­re­vair fol­low­ing pos­i­tive in­ter­im da­ta 

In­cyte touts Mon­ju­vi da­ta from Phase 3 fol­lic­u­lar lym­phoma tri­al as it heads to FDA

Gilead buys ex­per­i­men­tal HIV vac­cines from a small Barcelona biotech

A service from the Financial Times